M P3 (Paroxetine Extended-Release 12.5 mg)
Pill imprint M P3 has been identified as Paroxetine hydrochloride extended-release 12.5 mg.
Paroxetine is used in the treatment of anxiety and stress; anxiety; depression; obsessive compulsive disorder; postmenopausal symptoms (and more), and belongs to the drug class selective serotonin reuptake inhibitors. Excluding Brisdelle: There is positive evidence of human fetal risk during pregnancy. Brisdelle: Not for use in pregnancy. Paroxetine 12.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- M P3
- 12.5 mg
- 8.00 mm
- Prescription only
- Drug Class:
- Selective serotonin reuptake inhibitors
- Pregnancy Category:
- D - Positive evidence of risk - excluding Brisdelle
X - Not for use in pregnancy - Brisdelle
- CSA Schedule:
- Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- ferrosoferric oxide
hydroxypropyl cellulose (type h)
methacrylic acid - ethyl acrylate copolymer (1:1) type a
|NDC Code||Manufacturer / Repackager|
|51079-0824||UDL Laboratories Inc|
|21695-0552||Rebel Distributors Corp (repackager)|
Note: Inactive ingredients may vary.
More about paroxetine
- Paroxetine capsules
- Paroxetine controlled-release tablets
- Paroxetine mesylate
- Paroxetine suspension
- Paroxetine (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.